13.51
+0.32(+2.43%)
Currency In USD
| Previous Close | 13.19 |
| Open | 13.06 |
| Day High | 13.85 |
| Day Low | 12.93 |
| 52-Week High | 16.74 |
| 52-Week Low | 3.5 |
| Volume | 3.59M |
| Average Volume | 1.96M |
| Market Cap | 2.06B |
| PE | -12.06 |
| EPS | -1.12 |
| Moving Average 50 Days | 14.09 |
| Moving Average 200 Days | 8.03 |
| Change | 0.32 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) since IPO date, it would be worth $844.38 as of December 21, 2024 at a share price of $13.51. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $858.87 as of December 21, 2024 at a share price of $13.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 16, 2024 1:30 PM GMT
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno,
Wave Life Sciences to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 26, 2024 1:30 PM GMT
CAMBRIDGE, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno,
Wave Life Sciences to Present at Jefferies London Healthcare Conference
GlobeNewswire Inc.
Nov 15, 2024 1:30 PM GMT
CAMBRIDGE, Mass., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno,